FDA Approval Won't Make Stem Cell Therapy Cheaper | #195

If you're holding off on stem cell therapy because you're waiting for FDA approval to bring the price down, this is the reality check you need.

Dr. Joy Kong, a triple board certified physician and stem cell specialist at Chara Health, breaks down what FDA approved stem cell products actually cost. Cord blood transplants like Omidacel and AlloCord run $450,000 to $1.2 million. Ryoncil, used for pediatric graft versus host disease, totals $1.55 million. By comparison, current stem cell therapy provided as a legal tissue transplant, the same model used in organ transplants, costs $7,000 to $25,000 per infusion.

Dr. Joy explains why that gap exists, and what it means if you're counting on insurance to make this treatment affordable.

✨ Learn more about how to live a long and pain-free life: https://joykongmd.com/

Dr. Joy talks about:

0:21 Why FDA Approval Doesn't Lower Cost

2:26 Cost Of FDA-Approved Stem Cell Products

3:40 Why Legal Stem Cell Therapy Is Cheaper

Additional Resources

Visit My Clinic: Chara Health

🌐 https://chara-health.com

📍 9568 Topanga Canyon Blvd. Los Angeles, CA 91311

📲 Call (818) 356-8232 or email [email protected] to make an appointment or go to https://www.joykongmd.com and fill out a contact form.

✨ Follow me on Facebook: https://www.facebook.com/stemcelldrjoy/

✨ Follow me on Instagram: https://www.instagram.com/dr_joy_kong/

About Dr. Joy Kong

Dr. Joy Kong is a regenerative medicine and anti-aging expert. Her podcast is part of her mission to reduce suffering and elevate happiness. Join us every week for the latest holistic health insights that will help you live a long and pain-free life.